Placebo News and Research

RSS

Ketone supplements may be a new therapeutic strategy for improving brain health in obese people

The New research published in The Journal of Physiology has shown that ketone supplements may be a novel therapeutic strategy for protecting and improving brain health in people with obesity.

4 Oct 2021

Existing drug used to treat constipation may boost people's ability to think more clearly

The development of drugs to treat cognitive problems in patients with mental illness may be a step closer after a team of researchers discovered that an existing drug - used to treat constipation - may be able to boost our ability to think more clearly.

4 Oct 2021

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

The phase 1-2 clinical trials conducted using REGEN-COV had shown promising therapeutic benefits in COVID-19 outpatients. Its effect was further investigated in the present phase 3 clinical trial, the findings of which have been published in the "The New England Journal of Medicine".

3 Oct 2021

Depressed adolescents' brains give a muted reaction to distressing images, research finds

Scientists have measured brain activity in young people with and without depression, and found that the brains of depressed adolescents give a muted reaction to distressing images.

3 Oct 2021

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC).

2 Oct 2021

Aerobic exercise can help accelerate recovery after sport-related concussion in adolescents

Adolescents can speed their recovery after a sport-related concussion and reduce their risk of experiencing protracted recovery if they engage in aerobic exercise within 10 days of getting injured, according to a new University at Buffalo study.

1 Oct 2021

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding.

30 Sep 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.

30 Sep 2021

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led research.

29 Sep 2021

Large trial finds little effect of antibiotic amoxicillin for treating chest infections in children

The largest randomized placebo-controlled trial of the antibiotic amoxicillin for treating chest infections in children - one of the most common acute illnesses treated in primary care in developed countries, has found it is little more effective at relieving symptoms than the use of no medication.

28 Sep 2021

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.

27 Sep 2021

B cell activating anti-CD73 antibody for the immunotherapy of COVID-19

Despite the advent of numerous vaccines and the discovery of passive monoclonal antibodies for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), there remains an urgent need for definitive therapies for coronavirus disease-2019 (COVID-19) patients.

27 Sep 2021

Women with type 2 diabetes and CVD less likely to reach treatment targets than men, study finds

Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.

27 Sep 2021

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

A recent study supports the efficacy of the mRNA-1273 vaccine in preventing COVID-19 illness and disease severity.

24 Sep 2021

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

A new study presents initial results from a randomized, placebo-controlled phase 1/2 trial in Thailand.

24 Sep 2021

A daily pill to treat covid could be just months away, scientists say

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room.

24 Sep 2021

Placebo News and Research

Ketone supplements may be a new therapeutic strategy for improving brain health in obese people

Existing drug used to treat constipation may boost people's ability to think more clearly

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

Depressed adolescents' brains give a muted reaction to distressing images, research finds

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Aerobic exercise can help accelerate recovery after sport-related concussion in adolescents

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Large trial finds little effect of antibiotic amoxicillin for treating chest infections in children

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

B cell activating anti-CD73 antibody for the immunotherapy of COVID-19

Women with type 2 diabetes and CVD less likely to reach treatment targets than men, study finds

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

A daily pill to treat covid could be just months away, scientists say

Research demonstrates a clear link between nicotine withdrawal and poor eating habits

Diabetes drug may help to prolong pregnancy in women with preterm pre-eclampsia

Is the Pfizer-BioNTech COVID vaccine still effective after 6 months?

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News